학술논문
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
Document Type
Article
Author
Lorenzen, Sylvie; Götze, Thorsten Oliver; Thuss-Patience, Peter; Biebl, Matthias; Homann, Nils; Schenk, Michael; Lindig, Udo; Heuer, Vera; Kretzschmar, Albrecht; Goekkurt, Eray; Haag, Georg Martin; Riera-Knorrenschild, Jorge; Bolling, Claus; Hofheinz, Ralf-Dieter; Zhan, Tianzuo; Angermeier, Stefan; Ettrich, Thomas Jens; Siebenhuener, Alexander Reinhard; Elshafei, Moustafa; Bechstein, Wolf Otto
Source
Journal of Clinical Oncology; 2/1/2024, Vol. 42 Issue 4, p410-420, 14p
Subject
Language
ISSN
0732183X